Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.39b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Directorate Change

5 Mar 2020 09:21

RNS Number : 1288F
Jardine Matheson Hldgs Ltd
05 March 2020
 

Jardine Matheson Holdings Limited

Directorate Change

 

Jardine Matheson Holdings Limited (the 'Company') announces that, with effect from 15th June 2020, the roles of Executive Chairman and Managing Director, which have been held on a combined basis by Ben Keswick since December 2018, will revert to being separate roles.

 

Ben Keswick will remain as Executive Chairman and John Witt, currently Group Finance Director, will take on the role of Managing Director.

 

John joined Jardines in 1993 and held a range of senior roles across the Group's core businesses and geographies, including as chief financial officer of Hongkong Land and Mandarin Oriental, before being appointed to the Jardine Matheson Board in 2016.

 

John will also be a director of Jardine Strategic Holdings Limited and the Group's listed subsidiaries, Hongkong Land Holdings Limited, Dairy Farm International Holdings Limited and Mandarin Oriental International Limited. He will also continue to be a commissioner of Astra and chairman of the Astra Excom.

 

Graham Baker will replace John as Group Finance Director and will join the Group on 1st June 2020 from Smith + Nephew in the United Kingdom, where he has been a board member and chief financial officer since March 2017. Graham will join the Board of the Company.

 

Prior to joining Smith + Nephew, Graham worked for 20 years for AstraZeneca PLC in a range of senior roles in the UK and internationally, including in Japan and Singapore, and then as chief financial officer of generic pharmaceuticals company Alvogen.

 

Commenting on the changes, Ben Keswick said:

"I am confident that these appointments will strengthen and enhance the effectiveness of the Group's leadership as we respond to the challenges and opportunities we face in positioning Jardines for continuing long term success."

 

- end -

 

For further information please contact

 

Investor enquries:

Jonathan Lloyd

Jardine Matheson Limited

 

(852) 2843 8223

 

Media enquiries:

Brunswick

Tom Burns

 

(44) 207 404 5959

David Ashton

(852) 3512 5063

 

This and other Group announcements can be accessed at www.jardines.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUPUBAWUPUURA
Date   Source Headline
17th Mar 20259:41 amRNSDirector/PDMR Shareholding
13th Mar 202511:15 amRNSPT DFI RETAIL NUSANTARA TBK FULL YEAR 2024 RESULTS
10th Mar 202512:07 pmRNS2024 PRELIMINARY RESULTS
10th Mar 20259:46 amRNS2024 PRELIMINARY RESULTS
7th Mar 202512:13 pmRNS2024 PRELIMINARY RESULTS
5th Mar 20251:42 pmRNS2024 PRELIMINARY RESULTS
27th Feb 20251:13 pmRNSJC&C - 2024 FY Results and Dividend
27th Feb 202512:28 pmRNSPT Astra – 2024 Full Year Financial Statements
24th Feb 20259:23 amRNSDirectorate Change
31st Jan 20259:16 amRNSTotal Voting Rights
21st Jan 20259:51 amRNSHolding(s) in Company
13th Jan 202512:09 pmRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
11th Dec 202410:08 amRNSDirectorate Changes
10th Dec 20249:27 amRNSHolding(s) in Company
14th Nov 20249:49 amRNSInterim Management Statement
14th Nov 20249:43 amRNSINTERIM MANAGEMENT STATEMENT
14th Nov 20249:42 amRNSINTERIM MANAGEMENT STATEMENT
14th Nov 20249:42 amRNSINTERIM MANAGEMENT STATEMENT
13th Nov 20249:46 amRNSJC&C Interim Management Statement
31st Oct 202410:17 amRNSTotal Voting Rights
31st Oct 20249:26 amRNSPT Hero Supermarket Tbk Nine Months 2024 Results
30th Oct 202410:23 amRNSPT Astra 2024 Third Quarter Financial Statements
30th Oct 20249:29 amRNSDirector/PDMR Shareholding
29th Oct 202410:33 amRNSDirector/PDMR Shareholding
25th Oct 202410:34 amRNSDirector/PDMR Shareholding
18th Oct 202410:33 amRNSDirector/PDMR Shareholding
9th Oct 202411:27 amRNSDirector/PDMR Shareholding
9th Oct 202410:22 amRNSAdditional Listing
7th Oct 202411:45 amRNSDirector/PDMR Shareholding
2nd Oct 202410:24 amRNSDividend
27th Sep 202411:30 amRNSDividend
25th Sep 202410:40 amRNSBlock listing Interim Review
23rd Sep 20241:01 pmRNSDisposal of Shares in Yonghui Superstores
9th Sep 202410:27 amRNSDirector/PDMR Shareholding
4th Sep 202410:21 amRNSCirc re. Scrip Dividend Scheme
14th Aug 202411:08 amRNSDirector/PDMR Shareholding
1st Aug 202412:22 pmRNSHalf-Year Results
1st Aug 202410:56 amRNSJC&C 2024 Half-Year Results
1st Aug 202410:39 amRNSHalf-Year Results
1st Aug 202410:22 amRNSHalf-Year Results
31st Jul 202411:10 amRNSPT HERO SUPERMARKET TBK FIRST HALF 2024 RESULTS
30th Jul 202411:06 amRNSPT Astra 2024 First Half Financial Statements
24th Jul 20243:06 pmRNSHalf-year Report
2nd Jul 20241:12 pmRNSDirector/PDMR Shareholding
28th Jun 202410:25 amRNSDirector/PDMR Shareholding
27th Jun 202410:28 amRNSEXTRACTIVE SECTOR: PAYMENTS TO GOVTS REPORT 2023
26th Jun 202410:29 amRNSDirector/PDMR Shareholding
26th Jun 202410:28 amRNSDirector/PDMR Shareholding
24th Jun 202410:25 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.